Verve Therapeutics (VERV) Stock Price
$7.28 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
2 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Verve Therapeutics, AI stock picks, stock alerts and much more.
VERV AI Stock Analysis
AI stock analysis for VERV is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Verve Therapeutics (VERV) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Verve Therapeutics (VERV) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Verve Therapeutics (VERV), currently trading at $7.28, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About VERV
-
Verve Therapeutics, Inc.
-
Symbol
VERV
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
616.4M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
 |
Moderna MRNA |
$35.53 5.3% |
4 |
 |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
VERV Alternative Data
Web Traffic
Verve Therapeutics receives an estimated 17891 monthly visitors to vervetx.com.
-
Web Traffic
17891
-
Change from Previous Month
1.7%
-
3 Month Change
9.8%
-
YoY Change
9.8%
News Mentions
Verve Therapeutics was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Verve Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
Twitter Followers
Verve Therapeutics has 4,869 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.2% over the last month.
-
Twitter Followers
4869
-
Daily Change
0%
-
1 Month Change
0.2%
-
3 Month Change
0.2%
LinkedIn Followers
35,571 are following Verve Therapeutics on LinkedIn, up by 2.6% over the last month.
-
LinkedIn Followers
35571
-
Daily Change
0.1%
-
1 Month Change
2.6%
-
3 Month Change
5.3%
Job Postings
Verve Therapeutics currenly has an estimated 11 open job postings, up by 37.5% over the last month.
-
Job Postings
11
-
Daily Change
10%
-
1 Month Change
37.5%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, Verve Therapeutics has 301 employees, up by 1.3% over the last month.
-
LinkedIn Employees
301
-
Daily Change
0%
-
1 Month Change
1.3%
-
3 Month Change
1%
Business Outlook
-
Business Outlook
87
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
VERV Financials
VERV Key Metrics
-
Total Revenue
$6.9M
-
Net Income
-$50.1M
-
Earnings per Share
-$0.6
-
Free cash flow
-$40.5M
-
EBITDA
-$56.9M
-
EBITDA Ratio
-8.28988
-
Total Assets
$663.9M
VERV 2-year Revenue & Income
VERV 2-year Free Cash Flow
VERV Technicals
VERV SMA
VERV RSI
FAQ
What's the current price of Verve Therapeutics (VERV) Stock?
The price of an Verve Therapeutics (VERV) share is $7.28.
What's the market cap of Verve Therapeutics?
The current market cap of Verve Therapeutics is 616.4M.
Should I buy or sell VERV?
Verve Therapeutics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Verve Therapeutics is better viewed as a hold or accumulate position while waiting for further developments.
Is Verve Therapeutics a good investment?
The current analysis of Verve Therapeutics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Verve Therapeutics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Verve Therapeutics (VERV) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Verve Therapeutics stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Verve Therapeutics (VERV) that investors often compare it to?
Verve Therapeutics (VERV) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Verve Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Verve Therapeutics' stock price to be around $6.9 in 2026. Starting from the current price of $7.28, this represents a 5.3% change in price, indicating a bearish outlook for the stock.
How to buy Verve Therapeutics (VERV) Stock?
Verve Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Verve Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.